Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | BACE1 | P56817 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8794846 | 0.88 | KDM4E (0.35) | KMT2AMEN1KDM4EBACE1MAPK1 | |
| SCHEMBL8773869 | 0.71 | POLB (0.41) | KMT2AMEN1KDM4EBACE1MAPK1 | |
| SCHEMBL9031190 | 0.70 | ALDH1A1 (0.49) | KMT2AMEN1KDM4EMAPK1ALDH1A1 | |
| SCHEMBL8794840 | 0.69 | LMNA (0.54) | KMT2AMEN1KDM4EBACE1CA1 | |
| SCHEMBL7264596 | 0.69 | KMT2A (0.54) | KMT2AMEN1ALDH1A1MAPTTSHR | |
| SCHEMBL7810225 | 0.68 | CA1 (0.45) | KMT2AMEN1KDM4EBACE1CA1 | |
| SCHEMBL7801589 | 0.67 | ALDH1A1 (0.47) | KMT2AMEN1KDM4EBACE1MAPK1 | |
| SCHEMBL4342782 | 0.67 | PDE4A (0.46) | BACE1ALDH1A1MAPTTSHRIDO1 | |
| SCHEMBL26627961 | 0.67 | BACE1 (0.42) | KMT2AMEN1BACE1MAPK1ALDH1A1 | |
| SCHEMBL10471341 | 0.66 | TTR (0.52) | KMT2AMEN1KDM4EMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994018161-A1 | SUBSTITUTED PHENYL SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 1994-08-18 | — | — | WO | disclosed |